Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lentiviral protein delivery of meganucleases in human cells mediates gene targeting and alleviates toxicity.

Gene therapy·2014
Same author

In situ retrovirus-mediated gene transfer into the liver.

Methods in molecular medicine·2014
Same author

Delivery of therapeutic proteins from genetically-modified cells.

Restorative neurology and neuroscience·2011
Same author

Relevance of an academic GMP Pan-European vector infra-structure (PEVI).

Current gene therapy·2010
Same author

Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells.

Cytotechnology·2008
Same author

AAV vectors for RNA-based modulation of gene expression.

Gene therapy·2008

Related Experiment Video

Updated: Jun 3, 2026

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection
11:28

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Published on: May 23, 2016

Construction of Retro viral Packaging Cell Lines.

O Danos1

  • 1Institut Pasteur, Paris, France.

Methods in Molecular Biology (Clifton, N.J.)
|March 11, 2011
PubMed
Summary

Retrovirus vectors require specific cis-acting sequences for gene expression and packaging. Helper-free retrovirus stocks are crucial for safety and accurate research applications, avoiding recombination issues and helper virus infections.

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Background:

  • Retrovirus vectors are engineered to carry therapeutic genes, retaining essential cis-acting sequences for their lifecycle.
  • Viral functions not retained in the vector must be supplied in trans for particle assembly.

Purpose of the Study:

  • To highlight the necessity of helper-free retrovirus stocks for safe and reliable gene transfer applications.
  • To explain the limitations and risks associated with using replication-competent helper viruses.

Main Methods:

  • The abstract discusses the genetic components of retrovirus vectors and the implications of using helper viruses.
  • It outlines the requirements for producing functional retroviral particles.

Main Results:

More Related Videos

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells
09:40

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Published on: December 4, 2007

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites
09:31

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites

Published on: March 22, 2016

Related Experiment Videos

Last Updated: Jun 3, 2026

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection
11:28

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Published on: May 23, 2016

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells
09:40

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Published on: December 4, 2007

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites
09:31

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites

Published on: March 22, 2016

  • Using replication-competent helper viruses leads to mixed populations with a high risk of recombination, generating potentially unsafe viral chimeras.
  • Helper-free stocks are essential for accurate cell lineage analysis and to prevent complications in in vivo gene transfer studies.

Conclusions:

  • Helper-free retrovirus stocks are indispensable for advancing gene therapy and molecular research.
  • Minimizing recombination events and helper virus-induced pathologies is critical for experimental integrity and patient safety.